N
Navigating Cancer
Welcome to Navigating Cancer - Navigating Cancer
About Navigating Cancer
Navigating Cancer, founded in 2008, operates a comprehensive patient engagement and care management platform focused on the oncology sector. The company was established by Gena Cook, a healthcare and technology veteran, who was joined by co-founder Michael Graff in 2009. Cook's background in pharmaceutical sales at Bristol-Myers Squibb and Graff's experience at tech companies like Ancestry.com and Microsoft informed their mission to address a critical gap in cancer care by improving the patient experience through technology.
The firm's primary offering is the Navigating Care platform, a digital health solution that provides services to oncology practices, clinics, and their patients. The business model is centered on providing a suite of tools that enhance patient-provider communication, streamline clinical workflows, and improve care outcomes. Key features include a patient portal for accessing health records and secure messaging, a mobile application for remote monitoring and symptom reporting (Health Tracker), and tools for delivering personalized patient education. By integrating with electronic health record (EHR) systems, the platform helps care teams manage patients proactively, which has been shown to reduce hospitalizations and lower costs. The company generates revenue by enabling practices to improve success with value-based care programs and shared savings models.
Significant milestones include raising a total of $41.4 million over four funding rounds, with a notable Series D round of $26 million in 2019 led by Merck Global Health Innovation Fund and TT Capital Partners. In September 2024, Navigating Cancer was acquired by OneOncology, a platform for independent oncology practices. Following the acquisition, Navigating Cancer continues to operate as a standalone business, serving all community oncology practices regardless of their affiliations. The acquisition is intended to accelerate investment in the platform's technology, enhancing its capabilities without additional cost to its customers. The platform currently supports approximately 2,000 providers and over one million patients.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
Growth signals
Latest recorded traffic for Navigating Cancer is 2.5K monthly website visits, up 56.3% over the last three months. Navigating Cancer's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Navigating Cancer in the Nashville ecosystem
The Navigating Cancer office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later5 investors entered at this stage
Western Technology Investment
Rustic Canyon Partners
ORIX USA Corporation
Merck Global Health Innovation Fund
TT Capital Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Navigating Cancer on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Navigating Cancer’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









